---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-000481"
form_type: "8-K"
ticker: "CCEL"
cik: "0000862692"
company_name: "CRYO CELL INTERNATIONAL INC"
filed_at: "2022-01-25T23:59:59+00:00"
generated_at: "2026-06-27T16:04:55.324482+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Cryo-Cell receives Nasdaq notice for audit committee non-compliance; cure period until Sept 2022

## Summary
- Nasdaq notified that audit committee has only 2 independent members, needs 3 per Rule 5605.
- Cure period: earlier of next annual meeting or September 20, 2022 (or March 21, 2022 if meeting before that).
- Company must submit documentation evidencing compliance by the cure deadline.
- Cryo-Cell states it is working diligently to regain compliance within the cure period.

## SEC filing metadata
- accession: 0000950170-22-000481
- form_type: 8-K
- ticker: CCEL
- cik: 0000862692
- company_name: CRYO CELL INTERNATIONAL INC
- filed_at: 2022-01-25T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/862692/000095017022000481/0000950170-22-000481-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/862692/000095017022000481/ccel-20220119.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-000481
- JSON: https://secwatch.observer/filing/0000950170-22-000481.json
- Plain text: https://secwatch.observer/filing/0000950170-22-000481.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.